Efficacy and Safety of HB-1 for Panic Disorder
Phase 2
Recruiting
- Conditions
- Panic DisorderMental Illness
- Interventions
- First Posted Date
- 2024-07-03
- Last Posted Date
- 2025-06-26
- Lead Sponsor
- Honeybrains Biotech LLC
- Target Recruit Count
- 240
- Registration Number
- NCT06483789
- Locations
- ๐ฆ๐บ
Paratus Clinical Research Canberra, Canberra, Australian Capital Territory, Australia
๐ฆ๐บParatus Clinical Research Western Sydney, Blacktown, New South Wales, Australia
๐ฆ๐บParatus Clinical Research Central Coast, Kanwal, New South Wales, Australia
Safety and Efficacy of HB-1 for Panic Disorder
- First Posted Date
- 2021-10-08
- Last Posted Date
- 2025-03-18
- Lead Sponsor
- Honeybrains Biotech LLC
- Target Recruit Count
- 86
- Registration Number
- NCT05071430
- Locations
- ๐บ๐ธ
Collaborative Neuroscience Research, Garden Grove, California, United States
๐บ๐ธLumos Psychiatric Services, San Jose, California, United States
๐บ๐ธInstitute of Living, Hartford, Connecticut, United States